Swiss Pharma Clears €37M Funding to Develop a New Class of Antibiotics
Swiss Polyphor has closed a €37M (CHF40M) private funding round to finance the development of…
April 12, 2017 - 3 minutes
Apollo Therapeutics
UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off
Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research.…
February 22, 2017 - 2 minutes
New €210M Life Sciences Fund is Launched in UK
Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing…
February 2, 2016 - 2 minutes
New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College…
January 27, 2016 - 3 minutes
